
Salarius Pharmaceuticals Investor Relations Material
Latest events

Q1 2025
13 May, 2025

Q4 2024
21 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Salarius Pharmaceuticals Inc
Access all reports
Salarius Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancers with unmet medical needs. The company specializes in epigenetic-based treatments, aiming to inhibit key cancer-related pathways and improve patient outcomes. The company is headquartered in Houston, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
SLRX
Country
🇺🇸 United States